Evidence map›Paper›PMID 34187920›Full record

ArticleSaudi medical journal2021

Prevalence and determinants of distress among oncology patients at a tertiary care medical city in Riyadh, Saudi Arabia.

Luluh Y Alsughayer, Lamees A Altamimi, Futoon S Alsaleh, Lamya Alsaghan, Ibrahim Alfurayh, Nashwa M Abdel-Aziz, Khalid A Alsaleh, Fahad D Alosaimi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Luluh Y AlsughayerFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Lamees A AltamimiFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Futoon S AlsalehFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Lamya AlsaghanFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Ibrahim AlfurayhFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Nashwa M Abdel-AzizFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Khalid A AlsalehFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Fahad D AlosaimiFrom the College of Medicine (Alsughayer, Altamimi, Alsaleh, Alsaghan); from the Psychiatry Department (Alfuraih, Alosaimi); Hematology-Oncology Center (Abdel-Aziz, Alsaleh), King Saud University, Riyadh, Kingdom of Saudi Arabia; and from the Department of Medical Oncology (Abdel-Aziz), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo estimate the prevalence of distress in patients with cancer in Saudi Arabia and to identify common psychosocial stressors in these patients. We also looked for associations between distress and psychological, sociodemographic, and medical factors.

methodsThis cross-sectional study was performed in the oncology outpatient clinic at King Saud University Medical City, Riyadh, Saudi Arabia, from January 2018 to December 2019. It included 280 patients with breast cancer, colorectal cancer, or lymphoma. Sociodemographic information was collected using questionnaire, along with information on medical history and any psychiatric history. Distress was assessed using the Distress Thermometer and Problem List. Satisfaction with social support was rated using the visual analog scale. All patients were screened for depression using the Patient Health Questionnaire 9-item depression scale and anxiety using the Generalized Anxiety Disorder 7-item scale.

resultsThe prevalence of distress in our study population was found to be 46%. Distress was associated with several practical, family, emotional, and physical stressors in the problem list. Logistic regression identified predictors of distress to be anxiety (odds ratio [OR] 8.7, confidence interval [CI] 1.98-38.24,

conclusionApproximately half of cancer patients were found to have distress. Anxiety, advanced cancer stage, and radiotherapy were independently associated with distress.

Indexed as

Breast NeoplasmsCross-Sectional StudiesFemaleHumansPrevalenceSaudi ArabiaTertiary Health CarecancerdistressoncologyprevalenceSaudi Arabia

Identifiers

PMID34187920
PMCPMC9195523
OpenAlexW3174156935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.